Your browser doesn't support javascript.
loading
Intravascular lithotripsy for severe coronary calcification: a systematic review.
Sheikh, Azeem S; Connolly, Derek L; Abdul, Fairoz; Varma, Chetan; Sharma, Vinoda.
Afiliação
  • Sheikh AS; Department of Cardiology, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK - drazeemsheikh@hotmail.com.
  • Connolly DL; Department of Cardiology, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK.
  • Abdul F; Department of Cardiology, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK.
  • Varma C; Department of Cardiology, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK.
  • Sharma V; Department of Cardiology, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK.
Minerva Cardiol Angiol ; 71(6): 643-652, 2023 Dec.
Article em En | MEDLINE | ID: mdl-34713678
INTRODUCTION: Coronary artery calcification remains a challenge in percutaneous coronary interventions, due to the higher risk of suboptimal result with subsequent poor clinical outcomes. Intravascular lithotripsy is a novel way of treating severe coronary calcification as it has the ability to modify calcium both circumferentially as well as transmurally, facilitating stent expansion and apposition. We conducted a systematic overview of the published literature on intravascular lithotripsy (IVL) assessing the efficacy and feasibility of IVL in treating severe coronary calcification. EVIDENCE ACQUISITION: Of the retrieved publications, 62 met our inclusion criteria and were included. A total of 1389 patients (1414 lesions) with significant coronary calcification or under-expanded stents underwent IVL. EVIDENCE SYNTHESIS: The mean age was 72.03 years (74.7% male). There was a significant improvement in acute and sustained vessel patency, with mean minimal lumen diameter of 2.78±0.46 mm, resulting in acute gain of 1.72±0.51 mm. The acute procedural success rate was 78.2 to 100% with in-hospital complication rate of 5.6 to 7.0%. The majority of the studies reported 30-day MACE, which was between 2.2 to 7.8%. CONCLUSIONS: The recent studies have highlighted that the use of IVL with adjuvant intracoronary imaging has revolutionized the way of treating heavily calcified, non-dilatable coronary lesions and is likely to succeed the conventional ways of treating these complex lesions. We need further studies to gauge the long-term efficacy and safety of IVL against techniques currently available for calcium modification including conventional balloons, cutting or scoring balloons, rotational atherectomy and laser atherectomy.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Calcinose Tipo de estudo: Systematic_reviews Limite: Aged / Female / Humans / Male Idioma: En Revista: Minerva Cardiol Angiol Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Calcinose Tipo de estudo: Systematic_reviews Limite: Aged / Female / Humans / Male Idioma: En Revista: Minerva Cardiol Angiol Ano de publicação: 2023 Tipo de documento: Article